YoSync & IIIT Bangalore launches India’s first-ever COVID-19 Blockchain Platform, BelYo

▴ yosync-iiit-bangalore-launches-covid19-blockchain-platform-belyo
Now India uses blockchain technology to fight COVID-19

YoSync, a startup incubated at IIITB-IMACX Studios, signed a research collaboration in agreement with IIIT Bangalore, to partner with BelfricsBT, a Malaysian based blockchain startup. The partnership is aimed at jointly developing a blockchain platform for COVID-19. The project has been funded by Mphasis’ CSR arm, the Mphasis F1 Foundation, as part of their larger outreach programme to tackle the COVID-19 pandemic in India.

This partnership has fast-tracked the development and rollout of BelYo – India’s ? rst-ever blockchain platform for COVID-19. BelYo uses the BelfricsBT Belrium blockchain platform to convert COVID-19 related clinical and vaccination data of citizens from their current physical form into digital assets which can be retrieved by any contact tracing app (like Aarogya Setu) via APIs. Using these APIs, an individual can scan and retrieve data (colour-coded results) by scanning a QR code. The whole process is 100% contactless and seamless at any point of entry during and post the COVID-19 crisis.

Speaking about the platform, Satish Shekar, Founder & CEO YoSync said, “Prime Minister Narendra Modi recently chaired a high-level meeting to evaluate the usage of technology to tackle the COVID-19 pandemic. He stressed the need for using the latest technological innovations to monitor and control the spread of COVID-19 across India, and very importantly, he emphasized how technology could play a key role during the vaccination stage.”

Prof. Sadagopan, Director-IIIT Bangalore and Chairman IIITB-IMACX Studios said, “We had initiated a COVID-19 challenge – Setu Bandhan, in association with Mphasis to support IIITB’s startups with research and funds. BelYo provides a solution that is the need of the hour. By creating digital assets on the blockchain it complements existing COVID-19 applications like Aarogya Setu, Apthamitra (in Karnataka) etc. Using its state-of-the-art multi-admin module layer, BelYo will be able to simplify the tracking of all the COVID-19 patients in India – from symptoms to vaccination certi?cates in a decentralized manner, without compromising on the privacy of data.”

“We believe in using innovation in technology as a catalyst to solve real-life problems and are excited about this application of blockchain which will address the nation’s monitoring requirements. Mphasis had had a long and fruitful association with IIIT Bangalore, from our collaboration to create a Centre of Excellence for Cognitive Computing, which focuses on supporting innovative technology-based projects with high impact potential and continues to stay invested,” said Nitin Rakesh, Chief Executive Officer, Mphasis.

Praveenkumar Vijayakumar, Founder & CEO of Belfrics Group said, “COVID-19 infections are on the rise both within India and across the world, and there is an urgent need to use technology to deal with this grave situation. With the help of financial support from Mphasis, we will be able to expedite platform rollout, expand operations, and onboard testing centers (hospitals and private labs) by the end of 2020.”

BelYo plans to issue certificates for COVID-19 clinical records as well as immunization certificates on blockchain at a cost of less than INR 20. The final documentation for COVID-19 will be the vaccination record of citizens when that stage is reached, which is when recording and retrieving such data becomes vital for any economic activity. BelYo is built to issue such digital certificates (clinical and immunity certi?cates) to “n” number of admins at state or municipal level, with the union government acting as ‘super admin’.

Tags : #YoSync #IIITBangalore #BelYo #Blockchain #BelfricsGroup #IIITB #IndiaCovidNewsAug6

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Empowering Consumers with Nutritional Information: FSSAI's New Labeling GuidelinesJuly 12, 2024
Innovative Migraine Research Uncovers Key Triggers and Pathways for PainJuly 12, 2024
Alarming Rise in Death's Due to HIV Among Students in Tripura: Urgent Need for ActionJuly 12, 2024
Amrita Vishwa Vidyapeetham is All Set to Produce Netravaad, an Innovative Technology for Speech Impairment July 11, 2024
Twice-Yearly Injection Shows 100% HIV Protection in Young WomenJuly 11, 2024
AIMS (Asian Hospital) Doctors Restore Disfigured Face of Road Accident VictimJuly 10, 2024
Will #PutPeopleFirst mantra drive HIV responses?July 10, 2024
Shiprocket and Snowflake AI Data Cloud to empower 1.5 lakh merchants of BHARAT to scale their data infrastructureJuly 10, 2024
Dr. Shilpa Vora, Marico expert shares tips on how you can safeguard your baby’s skin during the monsoon seasonJuly 10, 2024
Pre Budget 2024 (Ms. Deepshikha Sharma- CEO of Sharp Sight Eye Hospital) July 10, 2024
Rate of global warming caused by humans at an all-time high - research led by University of LeedsJuly 09, 2024
Dengue during Monsoon Season and Neurological Complications Associated with DengueJuly 09, 2024
Yodda Elder Care Renews Partnership with Medulance for Emergency ServicesJuly 09, 2024
Budget Expectation Quote- Dr. Sanjeev Singh, Medical Director, Amrita Hospital, FaridabadJuly 08, 2024
Honourable Justice R. Mahadevan, Chief Justice of Madras High Court, Chennai Inaugurates IIRSI 2024, India's Premier Convention on Eye SurgeryJuly 06, 2024
The Impact of Architecture on Academic Performance: How Exam Hall Design Affects Student SuccessJuly 06, 2024
Teen Dies from Brain-Eating Amoeba in Kerala: Fatal Naegleria fowleri Infections SurgeJuly 05, 2024
Chemotherapy Drug Linked to Long-Term Hearing Loss in Cancer SurvivorsJuly 05, 2024
Qatar Airways Chooses Çelebi India as Ground Handler for New Doha-Goa FlightsJuly 04, 2024
Zika Virus Alert in Maharashtra: Government's Proactive Steps for Public SafetyJuly 04, 2024